Vendor, Tonawanda, NY
Pine Pharmaceuticals LLC
UEI TCJXKNYD6WL5, CAGE 7JZE9
2 awards and $410,376 obligated between July 9, 2026 and August 20, 2026, 0% under full and open competition, against 1.0 offers on average where reported.
Industries
NAICS on the awards, by dollars.
| Pharmaceutical Preparation ManufacturingNAICS 325412 | $410,376 |
How it wins
Awards by competition, set-aside and type.
| Competed Under SAP | 1 |
| Not Competed Under SAP | 1 |
| Delivery Order | 1 |
| Purchase Order | 1 |
Awards
Every award in the window, by dollars obligated.
| Contract | Awarding office | Described as | Obligated |
|---|---|---|---|
| 75N98026F00003Delivery Order, July 9, 2026, Competed Under SAP | National Institutes of Health OlaoNational Institutes of Health | Niddk: Stable Isotopes Deuterium Oxide (D, 70%), Glycerol (D5 Glycerol), and Glucose (6,6 Deuterated Glucose)NAICS 325412, PSC 6505 | $410,843 |
| 75N94021P00105Purchase Order, August 20, 2026, Not Competed Under SAP, 1 offers | National Institutes of Health NichdNational Institutes of Health | Procurement of Intravenous Stable Isotope (Potassium Palmitate U-13C) for Metabolic ResearchNAICS 325412, PSC 6505 | -$466 |
- Places of performance
- New York
- Product and service codes
- 6505 Drugs and Biologicals
- Transactions
- 2 across 2 awards